Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria
Malaria accounts for an enormous burden of disease globally, with Plasmodium falciparum
accounting for the majority of malaria, and P. vivax being a second important cause …
accounting for the majority of malaria, and P. vivax being a second important cause …
Advances and challenges in malaria vaccine development
PD Crompton, SK Pierce… - The Journal of clinical …, 2010 - Am Soc Clin Investig
Malaria caused by Plasmodium falciparum remains a major public health threat, especially
among children and pregnant women in Africa. An effective malaria vaccine would be a …
among children and pregnant women in Africa. An effective malaria vaccine would be a …
A review of malaria vaccine clinical projects based on the WHO rainbow table
L Schwartz, GV Brown, B Genton, VS Moorthy - Malaria journal, 2012 - Springer
Abstract Development and Phase 3 testing of the most advanced malaria vaccine, RTS,
S/AS01, indicates that malaria vaccine R&D is moving into a new phase. Field trials of …
S/AS01, indicates that malaria vaccine R&D is moving into a new phase. Field trials of …
Challenges and strategies for developing efficacious and long-lasting malaria vaccines
Although there has been major recent progress in malaria vaccine development, substantial
challenges remain for achieving highly efficacious and durable vaccines against …
challenges remain for achieving highly efficacious and durable vaccines against …
[HTML][HTML] Recent advances in recombinant protein-based malaria vaccines
SJ Draper, E Angov, T Horii, LH Miller, P Srinivasan… - Vaccine, 2015 - Elsevier
Plasmodium parasites are the causative agent of human malaria, and the development of a
highly effective vaccine against infection, disease and transmission remains a key priority. It …
highly effective vaccine against infection, disease and transmission remains a key priority. It …
Host-parasite interactions during Plasmodium infection: Implications for immunotherapies
P Chandley, R Ranjan, S Kumar, S Rohatgi - Frontiers in Immunology, 2023 - frontiersin.org
Malaria is a global infectious disease that remains a leading cause of morbidity and mortality
in the developing world. Multiple environmental and host and parasite factors govern the …
in the developing world. Multiple environmental and host and parasite factors govern the …
Protection against malaria by MSP3 candidate vaccine
SB Sirima, S Cousens, P Druilhe - New England Journal of …, 2011 - Mass Medical Soc
Protection against Malaria by MSP3 Candidate Vaccine | New England Journal of Medicine Skip
to main content The New England Journal of Medicine homepage Advanced Search SEARCH …
to main content The New England Journal of Medicine homepage Advanced Search SEARCH …
Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36
NMQ Palacpac, E Ntege, A Yeka, B Balikagala… - PLoS …, 2013 - journals.plos.org
Background Up to now a malaria vaccine remains elusive. The Plasmodium falciparum
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …
serine repeat antigen-5 formulated with aluminum hydroxyl gel (BK-SE36) is a blood-stage …
Peptide-based vaccines
Vaccination is a cost-effective approach to prevent, treat, and eradicate infectious diseases
and cancer. Classical whole-organism vaccines may have several pitfalls such as the …
and cancer. Classical whole-organism vaccines may have several pitfalls such as the …
Blood-stage malaria vaccines—recent progress and future challenges
AL Goodman, SJ Draper - Annals of Tropical Medicine & …, 2010 - Taylor & Francis
Plasmodium falciparum malaria is a major global health problem, responsible for up to 1
million deaths each year. Major efforts have been made to develop an effective vaccine …
million deaths each year. Major efforts have been made to develop an effective vaccine …